KN5501 Cell Injection for Refractory SLE(CLEAR)

NCT07358988 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erthematosus (SLE)

Interventions

DRUG: KN5501 cell injection

Sponsor

Ruitherapeutics Co., LTD